WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.

Mycobacterium tuberculosis (Mtb), the hardy bacterial species that causes tuberculosis (TB), has an unexpected vulnerability that future drugs […]

They arrive at Marib General Hospital every day in their hundreds: adults and children wounded by the ongoing […]

Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod esagonowsky Wed, 12/22/2021 – 13:12

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir fkansteiner Wed, 12/22/2021 – 09:15

Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators aliu Wed, 12/22/2021 – 09:18

Research team from Chemnitz University of Technology, IFW Dresden and Max Planck Institute CBG presents a completely new […]

Despite myriad precautionary measures, virus-contaminated aerosols still pose a serious problem indoors. An invisible protective wall of UV-C […]

With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the […]

Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent […]